<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article197</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index_gpt.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/SEPSISPAM" style="display:block; margin-bottom:10px;">SEPSISPAM Original</a></li>
<h2><strong>SEPSISPAM</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "Mean Arterial Pressure Targets in Septic Shock". The New England Journal of Medicine. 2014. 370:1583-1593. PubMed • Full text • PDF<br/>
<br/>
<h2><strong>Contents</strong></h2><br/>
1 Clinical Question<br/>
2 Bottom Line<br/>
3 Major Points<br/>
4 Guidelines<br/>
5 Design<br/>
6 Population<br/>
6.1 Inclusion Criteria<br/>
6.2 Exclusion Criteria<br/>
6.3 Baseline Characteristics<br/>
7 Interventions<br/>
8 Outcomes<br/>
8.1 Primary Outcome<br/>
8.2 Secondary Outcomes<br/>
9 Criticisms<br/>
10 Funding<br/>
11 Further Reading<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
In patients with septic shock, does targeting a higher mean arterial pressure (80 to 85 mm Hg) compared to a lower target (65 to 70 mm Hg) affect mortality?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
In patients with septic shock, targeting a higher mean arterial pressure did not lead to significant differences in mortality at 28 or 90 days when compared to a lower target. In patients with chronic arterial hypertension, a higher mean arterial pressure reduced the need for renal-replacement therapy but not mortality.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/><br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
As of August 2017, Surviving Sepsis Campaign guidelines recommend an initial resuscitation target mean arterial pressure of at least 65 mm Hg in patients with septic shock.<br/>
<br/>
<h2><strong>Design</strong></h2><br/>
Multicenter, open-label, randomized controlled trial<br/>
N=776 patients with septic shock<br/>
High-target group (mean arterial pressure 80 to 85 mm Hg, n=388)<br/>
Low-target group (mean arterial pressure 65 to 70 mm Hg, n=388)<br/>
Setting: 29 centers in France<br/>
Enrollment: 2010-2011<br/>
Mean follow-up: 90 days<br/>
Analysis: Intention-to-treat<br/>
Primary outcome: Mortality at day 28<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
Inclusion Criteria<br/>
Age ≥18 years<br/>
Septic shock refractory to fluid resuscitation requiring vasopressors<br/>
Enrollment within 6 hours after vasopressor initiation<br/>
Exclusion Criteria<br/>
Incompetence to provide consent without a guardian<br/>
No affiliation with French health care system<br/>
Pregnancy<br/>
Recent enrollment in another mortality-focused interventional study<br/>
Clinician decision against resuscitation<br/>
Baseline Characteristics<br/>
Similar in both groups; majority critically ill based on scoring systems, confirmed infection, and organ dysfunction<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
Patients were assigned to vasopressor treatment to maintain either a high or low mean arterial pressure target, for a maximum of 5 days or until vasopressor weaning.<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
Primary Outcome<br/>
28-day mortality: No significant difference (High: 36.6% vs. Low: 34.0%; HR 1.07, 95% CI 0.84 to 1.38; P=0.57)<br/>
Secondary Outcomes<br/>
90-day mortality: No significant difference (High: 43.8% vs. Low: 42.3%; HR 1.04, 95% CI 0.83 to 1.30; P=0.74)<br/>
Increased incidence of newly diagnosed atrial fibrillation in high-target group<br/>
Significant interaction between the study group and hypertension stratum for kidney function<br/>
No significant differences in early fluid balance or length of ICU and hospital stay<br/>
<br/>
<h2><strong>Criticisms</strong></h2><br/>
Higher-than-targeted mean arterial pressures observed in both groups<br/>
Lower-than-expected rate of death led to an underpowered study<br/>
Increase in atrial fibrillation episodes in the high-target group<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
Funded by the French Ministry of Health<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
Not provided
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
